The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced a new Community of Practice for Digital Mental Health Technologies. In a post on its official blog, the regulator said the initiative is intended to strengthen regulatory understanding, shared learning and practical support for developers in one of the UK medtech sector’s fastest-growing areas.
The community is meant to bring together developers, clinicians, researchers, commissioners and regulatory specialists. Its objectives include helping developers interpret regulatory requirements and build compliance into product design earlier; identifying common challenges, particularly for small and medium-sized enterprises entering mental health; sharing experience from organisations already working through regulatory pathways; and improving dialogue between industry and regulators.
Survey to shape priorities
The MHRA has also opened a survey to help determine the community’s initial priorities. It seeks input from digital mental health technology developers and other stakeholders, covering current regulatory challenges, areas where clearer guidance is needed and ways to improve compliance support.
The agency encouraged broad participation so that the community reflects real-world needs rather than top-down assumptions. For developers, the survey offers a direct channel to influence future regulatory support and to help create a more predictable and transparent environment for innovation.
The announcement comes as digital mental health tools expand from therapeutic apps to AI-supported assessment products. The MHRA said the need for consistent, practical guidance has become more urgent as the sector grows. The notice did not specify membership arrangements, meeting schedules or deliverables.
